PFAS 'Forever Chemicals' Linked To Type 2 Diabetes
By Dennis Thompson HealthDay Reporter
Medically reviewed by Drugs.com

WEDNESDAY, July 23, 2025 — So-called “forever chemicals” could be increasing Americans’ risk of developing type 2 diabetes, a new study says.
Higher blood levels of per- and polyfluoroalkyl substances (PFAS) are associated with a significantly greater risk of developing type 2 diabetes, the form of the disease most closely tied to obesity, researchers reported Monday in the journal eBioMedicine.
Risk for type 2 diabetes increased by 31% as PFAS blood levels rose from low to moderate and from moderate to high, researchers found.
It appears that the forever chemicals could be affecting the body’s ability to regulate blood sugar levels, researchers wrote.
“Our study is one of the first to examine how these chemicals may disrupt the body’s metabolism in ways that increase diabetes risk, particularly in diverse U.S. populations,” lead researcher Vishal Midya, an assistant professor of environmental medicine at the Icahn School of Medicine at Mount Sinai in New York City, said in a news release.
PFAS are called “forever chemicals” because they combine carbon and fluorine molecules, one of the strongest chemical bonds possible. This makes PFAS removal and breakdown very difficult, researchers explained in background notes.
PFAS compounds have been used in consumer products since the 1940s, including fire extinguishing foam, nonstick cookware, food wrappers, stain-resistant furniture and waterproof clothing.
“PFAS are synthetic chemicals that resist heat, oil, water and stains, and are found in countless everyday consumer products,” Midya said. “Because they don’t break down easily, PFAS accumulate in the environment — and in human bodies.”
For the study, researchers analyzed blood samples from 180 people recently diagnosed with type 2 diabetes and compared them to 180 similar individuals without diabetes.
They found people’s PFAS levels were indeed associated with their risk for type 2 diabetes. PFAS also seemed to alter people’s metabolism of amino acids, carbohydrates and some drugs, researchers said.
For example, PFAS altered people’s levels of sulfolithocholyglycine, a key signaling molecule for coordinating and regulating metabolism of fats, blood sugar, drugs and energy, researchers wrote.
However, the nature of the study means a direct cause-and-effect link between PFAS and type 2 diabetes can’t be drawn, researchers noted.
Future research is needed to verify this link, and to figure out exactly why PFAS might alter metabolism in a way that would impact diabetes risk, researchers said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-24 00:00
Read more

- Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease
- Updated Guidance Improves Staging of HPV-Positive Oropharyngeal Cancer
- Thousands Laid off From NIH, FDA and CDC After Supreme Court Decision
- 27.2 Million People of All Ages Uninsured in 2024 in the United States
- Long-Term Obesity Linked to Expression of Aging Biomarkers
- Tuna Recalled in Seven States Over Listeria Fears
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions